{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:25:00Z","timestamp":1790810700426,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.actatropica.2020.105603","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:21:29Z","timestamp":1593181289000},"page":"105603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Effect of nitazoxanide on diarrhea: A systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"210","author":[{"given":"Mohammad Rashidul","family":"Hashan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled Mosaad","family":"Elhusseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Huu-Hoai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuan Minh","family":"Tieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Khai","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Huu Nhat","family":"Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thai Le Ba","family":"Nghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Quang","family":"Loc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Nhu","family":"Y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Samuel","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma Said","family":"Elkolaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad Mohamed","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tien","family":"Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2020.105603_bib0001","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0011-393X(98)85006-6","article-title":"Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt","volume":"59","author":"Abaza","year":"1998","journal-title":"Current Therapeutic Research"},{"key":"10.1016\/j.actatropica.2020.105603_bib0002","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2020.105603_bib0003","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2334-9-195","article-title":"High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial","volume":"9","author":"Amadi","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.actatropica.2020.105603_bib0004","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2165\/00003495-200767130-00015","article-title":"Nitazoxanide","volume":"67","author":"Anderson","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.actatropica.2020.105603_bib0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(02)07744-9","article-title":"Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study","volume":"359","author":"Berkman","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2020.105603_bib0006","first-page":"813","article-title":"Cryptosporidiosis in HIV-seropositive patients","volume":"85","author":"Blanshard","year":"1992","journal-title":"Q J Med"},{"key":"10.1016\/j.actatropica.2020.105603_bib0007","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/QCO.0b013e32833de052","article-title":"Treatment of cryptosporidiosis: do we know what we think we know?","volume":"23","author":"Cabada","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2020.105603_bib0008","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0035-9203(97)90531-9","article-title":"Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico","volume":"91","author":"Cabello","year":"1997","journal-title":"Transactions of the Royal Society of Tropical Medicine Hygiene"},{"key":"10.1016\/j.actatropica.2020.105603_bib0009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1550-7408.2002.tb00523.x","article-title":"In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites","volume":"49","author":"Cedillo-Rivera","year":"2002","journal-title":"J Eukaryot Microbiol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0011","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.mcg.0000177231.13770.07","article-title":"Infectious diarrhea in developed and developing countries","volume":"39","author":"Cheng","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.actatropica.2020.105603_bib0012","article-title":"Blastocystosis: nitazoxanide as a new therapeutic option","volume":"36","author":"Cimerman","year":"2003","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2020.105603_bib0013","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4269\/ajtmh.2003.68.384","article-title":"Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico","volume":"68","author":"Diaz","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.actatropica.2020.105603_bib0014","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/cid\/ciw391","article-title":"A prospective longitudinal cohort to investigate the effects of early life Giardiasis on growth and all cause diarrhea","volume":"63","author":"Donowitz","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0015","doi-asserted-by":"crossref","first-page":"e02102","DOI":"10.1128\/mBio.02102-15","article-title":"Small intestine bacterial overgrowth and environmental enteropathy in Bangladeshi children","volume":"7","author":"Donowitz","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.actatropica.2020.105603_bib0016","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1997.56.637","article-title":"Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa","volume":"56","author":"Doumbo","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.actatropica.2020.105603_bib0017","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1128\/AAC.40.10.2266","article-title":"In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms","volume":"40","author":"Dubreuil","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.actatropica.2020.105603_bib0018","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/136485908X267894","article-title":"The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide","volume":"102","author":"Escobedo","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0019","first-page":"687","article-title":"Experimentation des proprietes anthelminthiques de la nitazoxanide chez le chien, le chat et les ovins","volume":"131","author":"Euzeby","year":"1980","journal-title":"Revue de M\u00e9decine V\u00e9t\u00e9rinaire"},{"issue":"Suppl 1","key":"10.1016\/j.actatropica.2020.105603_bib0020","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.vaccine.2004.08.017","article-title":"Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children","volume":"22","author":"Fischer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2020.105603_bib0021","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: a new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0022","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jac\/dkr077","article-title":"Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole","volume":"66","author":"Freeman","year":"2011","journal-title":"Journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.actatropica.2020.105603_bib0023","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/318514","article-title":"Practice guidelines for the management of infectious diarrhea","volume":"32","author":"Guerrant","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0024","doi-asserted-by":"crossref","first-page":"CMT. S2297","DOI":"10.4137\/CMT.S2297","article-title":"Current approaches to the treatment of gastrointestinal infections: focus on nitazoxanide","volume":"1","author":"Halsey","year":"2009","journal-title":"Clinical Medicine Therapeutics"},{"key":"10.1016\/j.actatropica.2020.105603_bib0025g","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.actatropica.2020.105603_bib0025","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.actatropica.2020.105603_bib0026","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.actatropica.2020.105603_bib0027","first-page":"1","article-title":"Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children","volume":"240","author":"Hussien","year":"2013","journal-title":"J Egypt Soc Parasitol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0028","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.actatropica.2020.105603_bib0029","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3748\/wjg.15.1805","article-title":"Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides","volume":"15","author":"Keeffe","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1067\/mpd.2003.41","article-title":"Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency","volume":"142","author":"Kutukculer","year":"2003","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.actatropica.2020.105603_bib0031","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1080\/0960312031000102921","article-title":"Studies of food hygiene and diarrhoeal disease","volume":"13","author":"Lanata","year":"2003","journal-title":"Int J Environ Health Res"},{"key":"10.1016\/j.actatropica.2020.105603_bib0032","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1993.tb03419.x","article-title":"Loss of mucosal CD4 lymphocytes is an early feature of HIV infection","volume":"92","author":"Lim","year":"1993","journal-title":"Clinical Experimental Immunology"},{"key":"10.1016\/j.actatropica.2020.105603_bib0033","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2020.105603_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7942515","article-title":"Nitazoxanide in acute rotavirus diarrhea: a randomized control trial from a developing country","volume":"2017","author":"Mahapatro","year":"2017","journal-title":"J Trop Med"},{"key":"10.1016\/j.actatropica.2020.105603_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13099-016-0102-8","article-title":"The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells","volume":"8","author":"Mathur","year":"2016","journal-title":"Gut Pathog"},{"key":"10.1016\/j.actatropica.2020.105603_bib0036","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection","volume":"434","author":"Mattapallil","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2020.105603_bib0037","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/clind\/15.3.464","article-title":"Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States","volume":"15","author":"McAuley","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0038","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.actatropica.2020.105603_bib0039","doi-asserted-by":"crossref","unstructured":"M\u00e9graud, F., Occhialini, A., Rossignol, J.F., 1998. Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole. 42, 2836\u20132840.","DOI":"10.1128\/AAC.42.11.2836"},{"key":"10.1016\/j.actatropica.2020.105603_bib0040","article-title":"Evaluation of racecadotril in treatment of acute diarrhea in children","volume":"7","author":"Michael","year":"2014","journal-title":"Evaluation"},{"key":"10.1016\/j.actatropica.2020.105603_bib0041","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3389\/fmicb.2015.01208","article-title":"Drug development against the major diarrhea-causing parasites of the small intestine, Cryptosporidium and Giardia","volume":"6","author":"Miyamoto","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0042","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/596552","article-title":"Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study","volume":"48","author":"Musher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0043","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/506351","article-title":"Nitazoxanide for the treatment of Clostridium difficile colitis","volume":"43","author":"Musher","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0044","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jac\/dkl553","article-title":"Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide","volume":"59","author":"Musher","year":"2007","journal-title":"Journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.actatropica.2020.105603_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s15010-013-0496-x","article-title":"Treatment of recurrent Clostridium difficile infection: a systematic review","volume":"42","author":"O'Horo","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.actatropica.2020.105603_bib0046","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1046\/j.1365-2036.2001.01066.x","article-title":"Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru","volume":"15","author":"Ortiz","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.actatropica.2020.105603_bib0047","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.actatropica.2020.105603_bib0048","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.actatropica.2020.105603_bib0049","first-page":"b92","article-title":"Guidance on the conduct of narrative synthesis in systematic reviews","volume":"1","author":"Popay","year":"2006","journal-title":"A product from the ESRC methods programme Version"},{"key":"10.1016\/j.actatropica.2020.105603_bib0050","article-title":"Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection","author":"Rafiullah","year":"2011","journal-title":"Case Reports 2011"},{"key":"10.1016\/j.actatropica.2020.105603_bib0051","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/AAC.04832-14","article-title":"In vitro antimicrobial susceptibility patterns of Blastocystis","volume":"59","author":"Roberts","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.actatropica.2020.105603_bib0052","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1099\/jmm.0.065508-0","article-title":"Treatment failure in patients with chronic Blastocystis infection","volume":"63","author":"Roberts","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0053","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1757-4749-6-17","article-title":"Update on the pathogenic potential and treatment options for Blastocystis sp","volume":"6","author":"Roberts","year":"2014","journal-title":"Gut Pathog"},{"key":"10.1016\/j.actatropica.2020.105603_bib0054","first-page":"28216n","article-title":"New derivative of 2-benzamido-5-nitrothiazoles","volume":"83","author":"Rossignol","year":"1975","journal-title":"Chem Abstr"},{"key":"10.1016\/j.actatropica.2020.105603_bib0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0035-9203(98)90804-5","article-title":"A double-\u2018blind'placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico","volume":"92","author":"Rossignol","year":"1998","journal-title":"Transactions of the Royal Society of Tropical Medicine Hygiene"},{"key":"10.1016\/j.actatropica.2020.105603_bib0056","unstructured":"Rossignol, J.F., 1982. Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives. U.S. Patent 4,315,018, issued February 9, 1982."},{"key":"10.1016\/j.actatropica.2020.105603_bib0057","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(06)68852-1","article-title":"Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial","volume":"368","author":"Rossignol","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2020.105603_bib0058","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/322038","article-title":"Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0059","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1365-2036.2006.03128.x","article-title":"Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial","volume":"24","author":"Rossignol","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.actatropica.2020.105603_bib0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cgh.2005.12.020","article-title":"Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species","volume":"4","author":"Rossignol","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0061","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.trstmh.2007.04.001","article-title":"Nitazoxanide in the treatment of amoebiasis","volume":"101","author":"Rossignol","year":"2007","journal-title":"Transactions of the Royal Society of Tropical Medicine Hygiene"},{"key":"10.1016\/j.actatropica.2020.105603_bib0062","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1542-3565(05)00427-1","article-title":"Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis","volume":"3","author":"Rossignol","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0063","series-title":"Nitazoxanide in Treating Chronic Hepatitis C: in Vitro Activity and a Clinical Case Report","author":"Rossignol","year":"2006"},{"key":"10.1016\/j.actatropica.2020.105603_bib0064","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trstmh.2011.11.007","article-title":"Nitazoxanide for the empiric treatment of pediatric infectious diarrhea","volume":"106","author":"Rossignol","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.actatropica.2020.105603_bib0065","first-page":"63","article-title":"Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis","volume":"22","author":"Rossignol","year":"1984","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0066","unstructured":"R\u00fccker, G., Schwarzer, G., Krahn, U., K\u00f6nig, J., Netmeta: network meta-analysis using frequentist methods. R Package version 0.9 (2016)."},{"key":"10.1016\/j.actatropica.2020.105603_bib0067","first-page":"524","article-title":"Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood","volume":"37","author":"Schneider","year":"1995","journal-title":"Berlin Diarrhea\/Wasting Syndrome Study Group. Gut"},{"key":"10.1016\/j.actatropica.2020.105603_bib0068","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/2229-5070.113901","article-title":"Blastocystis: consensus of treatment and controversies","volume":"3","author":"Sekar","year":"2013","journal-title":"Trop Parasitol"},{"key":"10.1016\/j.actatropica.2020.105603_bib0069","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/AAC.46.7.2116-2123.2002","article-title":"Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori","volume":"46","author":"Sisson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.actatropica.2020.105603_bib0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5414\/CPP40213","article-title":"Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses","volume":"40","author":"Stockis","year":"2002","journal-title":"International journal of clinical pharmacology therapeutics"},{"key":"10.1016\/j.actatropica.2020.105603_bib0071","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijid.2008.09.014","article-title":"Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children","volume":"13","author":"Teran","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0072","series-title":"Handbook On Paediatric AIDS in Africa","author":"Tindyebwa","year":"2004"},{"key":"10.1016\/j.actatropica.2020.105603_bib0073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2012.01.004","article-title":"Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence","volume":"40","author":"Vardakas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.actatropica.2020.105603_bib0074","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2020.105603_bib0075","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2006-04-015172","article-title":"Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.actatropica.2020.105603_bib0076","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/14787210.2.1.43","article-title":"Nitazoxanide: a new broad spectrum antiparasitic agent","volume":"2","author":"White","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.actatropica.2020.105603_bib0077","series-title":"The Treatment of diarrhoea: a Manual For Physicians and Other Senior Health Workers (No. WHO\/FCH\/CAH\/05.1)","year":"2005"},{"key":"10.1016\/j.actatropica.2020.105603_bib0078","unstructured":"World Health Organization, 2008. Weekly Epidemiological Record, 2008, vol. 83, 09 [full issue]. Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire 8309, 77\u201388."},{"key":"10.1016\/j.actatropica.2020.105603_bib0079","unstructured":"World Health Organization, 2017. Diarrheal disease fact sheets (2017)."},{"key":"10.1016\/j.actatropica.2020.105603_bib0080","series-title":"Global Health Estimates 2016: Deaths By cause, age, sex, By Country and By Region (2000-2016)","year":"2018"},{"key":"10.1016\/j.actatropica.2020.105603_bib0081","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/CMR.17.1.72-97.2004","article-title":"Cryptosporidium taxonomy: recent advances and implications for public health","volume":"17","author":"Xiao","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2020.105603_bib0082","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.actatropica.2020.105603_bib0083","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2005.02394.x","article-title":"Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial","volume":"21","author":"Zulu","year":"2005","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19316328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X19316328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:26:32Z","timestamp":1757550392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X19316328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":84,"alternative-id":["S0001706X19316328"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2020.105603","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of nitazoxanide on diarrhea: A systematic review and network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2020.105603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105603"}}